| Product Name | PI4KIIIβ | PI4KIIIα | PI4K | PI4KII | Purity |
|---|---|---|---|---|---|
| (R)-GSK-F1 | |||||
| (S)-GSK-F1 | 98.01% | ||||
| AL-9 | 99.68% | ||||
| Antimalarial agent 41 | |||||
| AZD2836 | |||||
| BF738735 | 99.26% | ||||
| BI-1622 | 98.02% | ||||
| BQR-695 | 99.36% | ||||
| CHMFL-PI4K-127 | 99.94% | ||||
| Echiguanine A | |||||
| EDI048 | 99.86% | ||||
| GSK-A1 | 99.04% | ||||
| GSK-F1 | 95.06% | ||||
| KAI-407 | |||||
| KDU691 | 99.09% | ||||
| KDU731 | 99.52% | ||||
| KR-27370 | |||||
| KR-27452 | |||||
| MG degrader 2 | |||||
| MI 14 | 99.30% | ||||
| MMV390048 | 98.85% | ||||
| NC03 | 98.79% | ||||
| PI-273 | 98.47% | ||||
| PI4K-IN-1 | 98.59% | ||||
| PI4K-IN-2 | |||||
| PI4K-IN-3 | |||||
| PI4KA Human Pre-designed siRNA Set A | |||||
| Pi4ka Mouse Pre-designed siRNA Set A | |||||
| Pi4ka Rat Pre-designed siRNA Set A | |||||
| PI4KA-IN-1 | |||||
| PI4KB Human Pre-designed siRNA Set A | |||||
| Pi4kb Mouse Pre-designed siRNA Set A | |||||
| Pi4kb Rat Pre-designed siRNA Set A | |||||
| PI4KIII beta inhibitor 3 | 99.36% | ||||
| PI4KIII beta inhibitor 4 | |||||
| PI4KIII beta inhibitor 5 | |||||
| PI4KIIIbeta-IN-10 | 99.84% | ||||
| PI4KIIIbeta-IN-11 | |||||
| PI4KIIIbeta-IN-9 | 99.18% | ||||
| PI4Kβ-IN-1 | |||||
| PI4Kβ/PKG-IN-1 | |||||
| PI4Kβ/PKG-IN-2 | 99.34% | ||||
| PIK-93 | 99.74% | ||||
| Pipinib | |||||
| T-00127_HEV1 | 99.85% | ||||
| T-00127_HEV1 (Standard) | |||||
| UCB9608 | 99.59% | ||||
| UCT943 | 99.08% |
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号